Fondaparinux Sodium Injection, Solution
Product Images NDC 67457-582

Product Visual Gallery

This gallery contains 26 technical images submitted to the FDA as part of the official labeling for Fondaparinux Sodium (NDC 67457-582). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Mylan Institutional Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure A (Image 01)

Two black-and-white instructional illustrations depict preparation and administration of an injection. Figure 1 shows a hand holding a vial cap to be removed by pulling. Figure 2 shows a person receiving a subcutaneous injection in the abdominal area, with a hand administering the injection with a syringe.*

FDA Label Image

Figure B (Image 02)

Instructional illustrations showing subcutaneous injection technique with a syringe for Fondaparinux Sodium injection. The two figures depict hands administering the injection into the abdominal area, demonstrating proper needle insertion and injection site location for subcutaneous delivery.*

FDA Label Image

Figure C (Image 17)

An instructional illustration showing a hand holding a prefilled syringe for subcutaneous injection. The needle end is positioned near the skin, demonstrating the injection technique likely for Fondaparinux Sodium injection, solution.*

FDA Label Image

Fondaparinux Sodium Structural Formula (Image 03)

Chemical structure diagram of fondaparinux sodium, showing its complex molecular composition including multiple sugar ring units and sodium salt groups.*

FDA Label Image

Syringe Figure, Ifu (Image 04)

An instructional diagram showing a stepwise sequence for preparing or handling a prefilled syringe of medication. The image highlights four numbered parts or steps, focusing on the syringe tip, plunger, and barrel assembly likely related to Fondaparinux Sodium injection preparation or administration.*

FDA Label Image

Syringe Parts, Ifu (Image 05)

An instructional diagram showing a prefilled syringe used for subcutaneous injection. The syringe is labeled with numbered parts highlighting the plunger, barrel, and needle components. This image likely corresponds to Fondaparinux Sodium injection, solution by Mylan Institutional LLC.*

FDA Label Image

Syringe Before Use, Ifu (Image 06)

An instructional diagram of an injection device for Fondaparinux Sodium subcutaneous injection solution. The image highlights specific parts of the syringe with numbered callouts, showing the preparation or administration components of the injectable medication.*

FDA Label Image

Syringe After Use, Ifu (Image 07)

An instructional illustration showing a person preparing to administer a subcutaneous injection to their abdomen. The person is seated on a mat, pulling up their shirt to expose the injection site, and holding a syringe aimed at the abdomen area.*

FDA Label Image

Figure A, Ifu (Image 08)

Instructional illustration showing hands preparing a Fondaparinux Sodium prefilled syringe by removing a needle cap. The image indicates the proper method to unscrew or pull off the cap before subcutaneous injection.*

FDA Label Image

Figure B, Ifu (Image 09)

A black-and-white photograph showing a person with hands positioned on their lower abdomen. Two arrows point to the area of the abdomen where a subcutaneous injection is likely to be administered, demonstrating the injection site for Fondaparinux Sodium injection, solution.*

FDA Label Image

Figure C, Ifu (Image 10)

An instructional illustration showing a person administering a subcutaneous injection in the abdominal area using a syringe. The image demonstrates the proper technique for injecting Fondaparinux Sodium solution subcutaneously.*

FDA Label Image

Figure D, Ifu (Image 11)

An instructional illustration showing the proper technique for holding a syringe filled with Fondaparinux Sodium injection solution before subcutaneous administration. The image focuses on hand positioning and handling of the syringe to ensure correct dosage delivery.*

FDA Label Image

Figure E, Ifu (Image 12)

An instructional diagram showing how to administer a subcutaneous injection using a prefilled syringe. The image illustrates a hand holding the syringe at an angle, ready to inject into the skin, demonstrating proper technique for Fondaparinux Sodium injection.*

FDA Label Image

Figure F, Ifu (Image 18)

An instructional illustration showing a hand administering a subcutaneous injection using a prefilled syringe or pen, with an arrow indicating the direction for activating or pressing the device. This image relates to the injection route for Fondaparinux Sodium.*

FDA Label Image

Prepared Syringe Figure, Ifu (Image 19)

An illustration of a syringe with a needle attached, showing volume markings from 0.1 to 0.9 units. The syringe includes a plunger and a finger flange, typically used for subcutaneous injections.*

FDA Label Image

Figure A, Prepared Ifu (Figure A, Prepared Ifu)

Illustration of a syringe used for subcutaneous injection, showing a needle (1), barrel with measurement markings (2), and plunger (3). The syringe is intended for injecting Fondaparinux Sodium solution.*

FDA Label Image

Figure B, Prepared Ifu (Figure B, Prepared Ifu)

An instructional diagram showing the recommended injection site for Fondaparinux Sodium. The diagram depicts a human torso highlighting the lower stomach area (abdomen) as the location for subcutaneous injection.*

FDA Label Image

Figure C, Prepared Ifu (Figure C, Prepared Ifu)

An instructional diagram showing a person holding a syringe and vial, demonstrating the process of drawing medication from the vial into the syringe. The left hand stabilizes the vial, and the right hand pulls the syringe plunger to draw the liquid. An arrow indicates the direction of plunger movement.*

FDA Label Image

Figure C, Prepared Ifu (Image 20)

An instructional illustration showing a hand pinching the skin on a human arm, likely demonstrating the proper technique for subcutaneous injection administration.*

FDA Label Image

Figure D, Prepared Ifu (Image 21)

An instructional illustration showing the proper technique for subcutaneous injection. It depicts a hand holding a syringe vertically at a 90-degree angle, inserted into the skin of an arm or thigh, with an arrow indicating downward movement for injection.*

FDA Label Image

Figure E, Prepared Ifu (Image 22)

An instructional diagram depicting the administration of a subcutaneous injection using a syringe. The image shows one hand holding the syringe vertically above the injection site on skin, with an arrow pointing downward indicating the direction of needle insertion.*

FDA Label Image

Figure F, Prepared Ifu (Image 23)

An instructional illustration showing a hand administering a subcutaneous injection using a syringe. The syringe is inserted into the skin, and the other hand is pulling the syringe upward, indicating the injection technique relevant to subcutaneous administration.*

FDA Label Image

Fondaparinux Sodium Injection, Usp 2.5 mg/0.5 mL Carton Label (Image 13)

Packaging label for Fondaparinux Sodium Injection, USP, 2.5 mg/0.5 mL. It is for subcutaneous injection and contains 10 single-dose prefilled syringes with an automatic needle protection system. Labeler is Mylan Institutional LLC, with NDC 67457-582-10. The label includes dispensing instructions for pharmacists to provide patient information leaflets.*

FDA Label Image

Fondaparinux Sodium Injection, Usp 5 mg/0.4 mL Carton Label (Image 14)

Packaging label for Fondaparinux Sodium Injection, USP 5 mg/0.4 mL, a subcutaneous injection by Mylan Institutional LLC. The label states the product comes in 10 single-dose prefilled syringes with an automatic needle protection system. It includes instructions for pharmacists to dispense accompanying patient information and features the Mylan logo and barcode.*

FDA Label Image

Fondaparinux Sodium Injection, Usp 7.5 mg/0.6 mL Carton Label (Image 15)

Packaging label for Fondaparinux Sodium Injection, USP, 7.5 mg/0.6 mL, a subcutaneous injection by Mylan Institutional LLC. The label indicates that the package contains 10 single-dose prefilled syringes with an automatic needle protection system. The label includes dosing strength, administration route, manufacturer details, and a note for pharmacists to dispense a patient information leaflet.*

FDA Label Image

Fondaparinux Sodium Injection, Usp 10 mg/0.8 mL Carton Label (Image 16)

Packaging label for Fondaparinux Sodium Injection, USP, 10 mg/0.8 mL solution for subcutaneous injection. The label indicates the product comes as 10 single-dose prefilled syringes with an automatic needle protection system. It is manufactured by Mylan Institutional LLC. The label includes directions for pharmacists and storage information.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.